Ablaze Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Ablaze Pharma is a clinical stage bio-pharmaceutical company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients.
About
Industries
Biotechnology, Pharmaceutical, Medical
Founded
2011
Employees
11-50
Headquarters locations
Asia
Social
N/A
Profile Resume
Ablaze Pharmaceuticals headquartered in Asia, operates in the Biotechnology, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $900.0M in funding across 12 round(s). With a team of 11-50 employees, Ablaze Pharmaceuticals is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Ablaze Pharmaceuticals, raised $75.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
8
Lead Investors
0
Total Funding Amount
$75.0M
Details
1
Ablaze Pharmaceuticals has raised a total of $75.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 75.0M |
Investors
Ablaze Pharmaceuticals is funded by 10 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Norman Tse | - | FUNDING ROUND - Norman Tse | 75.0M |
| Aaron Royston | - | FUNDING ROUND - Aaron Royston | 75.0M |
| venBio Partners | - | FUNDING ROUND - venBio Partners | 75.0M |
| Ablaze Pharmaceuticals | - | FUNDING ROUND - Ablaze Pharmaceuticals | 75.0M |
Recent Activity
There is no recent news or activity for this profile.